Press release
Cancer Gene Therapy Market Anticipated to Grow Significantly by 2032 - Persistence Market Research
Cancer Gene Therapy Market
The cancer gene therapy market has seen a transformative evolution over the last decade, shifting from a narrow focus on monogenic diseases to emerging as a promising frontier in oncology. Cancer gene therapy involves the modification or manipulation of genetic material to combat or treat cancer, commonly by replacing faulty genes, silencing malfunctioning ones, or introducing new genes to strengthen the body's defense against cancerous cells.
North America leads the market, owing to its advanced healthcare infrastructure, robust R&D ecosystem, and strong presence of leading biopharmaceutical firms. Among treatment types, gene silencing therapies dominate, while Asia-Pacific is poised to register the highest growth rate due to rising healthcare investments and favorable government policies.
Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/2988
Key Highlights from the Report
• North America continues to hold the largest market share globally.
• Gene silencing remains the most widely adopted therapeutic technique.
• Asia-Pacific is expected to show the fastest market growth over the forecast period.
• Increased R&D investment is a key driver in expanding therapy pipelines.
• DNA-based vaccines are gaining popularity for their potential in cancer immunotherapy.
Market Segmentation
The cancer gene therapy market is segmented by therapy type, end-user, and delivery method. By therapy type, the market includes gene silencing, gene augmentation, and oncolytic virotherapy. Gene silencing dominates due to its effectiveness in shutting down faulty gene expression that fuels cancer progression. Meanwhile, oncolytic virotherapy, involving viruses that selectively infect and kill cancer cells, is gaining traction in advanced clinical trials.
By end-user, the market caters to hospitals, oncology research institutes, and specialty clinics. Hospitals remain the primary end-user segment due to access to multidisciplinary expertise and patient volume. However, research institutes are emerging as critical players in developing next-generation cancer gene therapies, thanks to increasing collaborations between academia and biotech firms.
Regional Insights
North America is the leading geographical region in the cancer gene therapy market, driven by high cancer prevalence, strong R&D infrastructure, and active support from both public and private sectors. The presence of major biotech companies and favorable regulatory frameworks also contribute to regional dominance.
In contrast, Asia-Pacific is emerging as a lucrative market due to increased cancer incidence, rapid economic development, and government initiatives aimed at strengthening healthcare systems. Countries like China, Japan, and India are witnessing increased clinical trial activity and regulatory advancements that support the deployment of gene therapy solutions.
Market Drivers
One of the primary drivers of the cancer gene therapy market is the increasing prevalence of cancer worldwide. With over 19 million new cases annually, the need for innovative treatments has become more urgent than ever. Additionally, rising investments in gene therapy research, both from government bodies and private entities, are accelerating the development of advanced therapies. Ethical acceptance and the growing clinical success of gene therapy in trials also bolster its adoption.
Market Restraints
Despite promising potential, the market faces some restraints. High treatment costs remain a significant barrier, making these therapies inaccessible to large patient populations, particularly in low-income regions. Moreover, limited awareness and lack of specialized infrastructure can hinder the adoption rate in emerging economies. Regulatory complexities and time-consuming approval processes also add layers of challenge.
Market Opportunities
The market is ripe with opportunities, particularly with pharmaceutical companies showing renewed interest in gene therapy. Despite high R&D costs, the potential for breakthroughs and patent exclusivity makes this a highly attractive investment area. Innovations like CRISPR-based gene editing and personalized cancer vaccines are pushing the boundaries of what's possible, creating fertile ground for growth and collaboration.
Reasons to Buy the Report
✔ Understand the current market landscape and forecast through 2032
✔ Gain insights into emerging therapies and technological innovations
✔ Identify regional growth hotspots and investment opportunities
✔ Evaluate the competitive landscape and key player strategies
✔ Make informed business decisions with reliable data and market projections
Company Insights
Key players operating in the cancer gene therapy market include:
1. Novartis AG
2. Gilead Sciences, Inc.
3. Adaptimmune Therapeutics plc
4. Kite Pharma (a Gilead Company)
5. Bluebird Bio, Inc.
6. Amgen Inc.
7. Sarepta Therapeutics
8. Genethon
9. Bristol-Myers Squibb Company
10. BioNTech SE
Recent Developments:
• In 2024, Bluebird Bio announced the successful trial results of its next-gen CAR-T therapy, significantly improving survival rates in patients with refractory cancers.
• Novartis expanded its gene therapy portfolio by acquiring a UK-based biotech focused on tumor-targeted gene editing technologies, enhancing its footprint in oncology-focused therapies.
Final Thoughts
The cancer gene therapy market is entering a golden era of innovation and investment. While challenges such as cost and awareness remain, the continued success of clinical trials and increasing support from governments and private sectors paint a bright future. With ongoing R&D, emerging technologies, and strategic collaborations, this field holds transformative potential not only for cancer treatment but for the broader healthcare landscape.
As we move towards more personalized and precise cancer therapies, gene therapy is poised to become a cornerstone of modern oncology, delivering hope where traditional treatments fall short.
About Persistence Market Research:
At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.
Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.
Contact Us:
Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Gene Therapy Market Anticipated to Grow Significantly by 2032 - Persistence Market Research here
News-ID: 3978432 • Views: …
More Releases from Persistence Market Research
Global Automotive Active Health Monitoring Systems Market Expected to Surge from …
The Automotive Active Health Monitoring Systems Market is poised for significant growth over the forecast period of 2025 to 2032. This market is projected to expand from USD 683.9 million in 2025 to USD 2,338.3 million by 2032, registering a robust CAGR of 19.20%. Automotive active health monitoring systems are designed to track the real-time status of vehicles, enabling predictive maintenance, reducing downtime, and enhancing overall vehicle safety. With growing…
Primary Packaging Labels Market to Reach US$12.2 Bn by 2031 with Steady Growth a …
➤Overview of the Market
The global primary packaging labels market is a crucial segment of the packaging industry, enabling product identification, regulatory compliance, and brand differentiation. Primary labels are applied directly on product packaging, such as bottles, vials, boxes, and pouches, serving both functional and promotional roles. As consumer awareness of product authenticity and safety continues to rise, demand for innovative labeling solutions is expanding. Moreover, stringent regulatory frameworks in industries…
Shelf Stable Packaging Market to Reach US$10.7 Bn by 2031 with Steady Growth at …
➤Overview of the Market
The shelf stable packaging market plays a critical role in extending the shelf life of food and beverages without the need for refrigeration, ensuring product safety, convenience, and affordability. These packaging solutions-spanning cartons, pouches, cans, and plastic containers-are widely used in ready-to-eat meals, dairy alternatives, sauces, soups, and beverages. Growth in the market is closely linked to evolving consumer lifestyles, increasing urbanization, and demand for long-lasting packaged…
Print Label Market to Reach US$68.6 Bn by 2031 with Steady Growth at 4.3% CAGR - …
➤Overview of the Market
The global print label market is poised for substantial expansion, driven by increasing demand across industries such as food & beverages, pharmaceuticals, cosmetics, and logistics. Labels play a crucial role in brand identity, product differentiation, and regulatory compliance. In addition to providing essential information like product ingredients, expiration dates, and barcodes, printed labels serve as key marketing tools that influence consumer purchase decisions. With the rapid rise…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
